Metabolism and obesity are the focus of a major research initiative by the University of Gothenburg and AstraZeneca, with the ...

Metabolism and obesity are the focus of a major research initiative by the University of Gothenburg and AstraZeneca, with the ...

near Gothenburg. This now looks odds-on to be shut down if Pfizer secures the takeover bid in the next few weeks. Many US commentators are predicting closure of Pfizer and AstraZeneca research ...

Maria joined AstraZeneca in 2017 as head of Respiratory ... in Cardiovascular Physiology/Pharmacology from the University of Gothenburg, Sweden. What inspired you to work in the life sciences ...

located in Gothenburg, Sweden. The new building, situated adjacent to AstraZeneca's key research location, will improve the company's laboratory services. The new 2694sqm facility is scheduled to ...

Under that deal, AstraZeneca would buy 200 gigawatt-hours per year for 10 years, which corresponds to roughly 80% of the company’s total electricity needs at its research facility in Gothenburg ...

AstraZeneca Plc said its experimental obesity pill was well tolerated by patients with type-2 diabetes as it presented data from several studies testing its three new weight-loss medicines. The ...

LONDON, Nov 4 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Monday its experimental weight-loss pill, licensed a year ago from China's Eccogene for up to $2 billion, was safe and ...

AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. The results showed promise against rival drugs from Merck and NewAmsterdam Pharma, but AstraZeneca stock fell ...